WHO INN approves ‘Usnoflast’ as recommended name for ZYIL1 from Zydus
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus. Studies have demonstrated that ZYIL1 is…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.